Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
Guillain-Barre Syndrome warning for AstraZeneca The TGA has updated the vaccine’s Product Information regarding the ‘very rare’ possibility of contracting the disorder.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
Inflammatory syndrome linked to SARS-CoV-2 can affect adults The CDC says the new adult syndrome closely resembles the previously identified paediatric one.
WHO develops preliminary case definition for inflammatory syndrome in children The COVID-19-associated syndrome seems to be its own unique entity.
‘Important’ link between paediatric inflammatory syndromes and COVID-19 Australian researchers have been commissioned to investigate the mystery illness, following the death of at least three children in the US.
‘I thought it was just me’: Registrars and impostor syndrome Feeling like a fraud is common for general practice registrars, but the issue is often shrouded in secrecy.
‘It’s not insomnia’: Shining a light on delayed sleep phase syndrome Patients with circadian rhythm disorders are commonly mislabelled as having insomnia, but the two conditions are managed very differently, Dr Evelyn Lewin writes.
‘It’s not PMS’: Shining a light on premenstrual dysphoric disorder The disorder was recently added to the WHO list of diseases, yet latest preliminary findings show it takes an average of 12 years for an Australian woman to be diagnosed.
Patients with untreated ‘white coat’ hypertension twice as likely to die from heart disease New research shines further light on the health risks of what is a common occurrence.